Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
Ergocalciferol treatment does Not improve erythropoietin utilization and hospitalization rate in hemodialysis patients
Gaurav Agarwal
, Padam Hirachan
,
Jonathan Gelfond
, Paolo Fanti
, Claudia Hura
,
Shweta Bansal
Department of Population Health Sciences
Department of Medicine
Division of Nephrology/Renal Diseases
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ergocalciferol treatment does Not improve erythropoietin utilization and hospitalization rate in hemodialysis patients'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
25 Hydroxyvitamin D
14%
Chronic Kidney Failure
14%
Cohort Study
28%
Coronary Artery Disease
14%
Ergocalciferol
100%
Erythropoietin
85%
Ferritin
14%
Hemodialysis
57%
Hemoglobin
14%
Mineral
14%
Paricalcitol
28%
Prevalence
14%
Transferrin
14%
Vitamin D
28%
Vitamin D Analogue
28%
Biochemistry, Genetics and Molecular Biology
Bone
14%
Dose
57%
Ergocalciferol
100%
Erythropoiesis
14%
Erythropoietin
85%
Ferritin Blood Level
14%
Hemodialysis
57%
Hemoglobin
14%
Mineral Metabolism
14%
Paricalcitol
28%
Prevalence
14%
Reduction (Chemistry)
14%
Transferrin Saturation
14%
Vitamin D
28%